The Global market of ECMO devices is driven by the rise in the number of patients going through the respiratory failures and cardiac-pulmonary ailments.
Albany, NY -- (SBWIRE) -- 01/02/2018 -- ECMO is extracorporeal membrane oxygenation. The ECMO device is analogous to the lung-heart by-pass system in open heart surgery or lung surgeries. ECMO device is a modified cardiopulmonary bypass circuit for temporary life support for the patients with cardiac or respiratory failure. The ECMO device offers gas exchange mechanism bypassing the heart and lungs. The ECMO device pumps the blood outside the body and oxygenates the blood, letting the lungs and heart to be at rest. When a patient is connected to an ECMO device, the blood flows across the artificial lung in the ECMO device, this oxygenates the blood and pumps out carbon dioxide. The blood is then brought to the body temperature by warming a bit and is then pumped back into the body. The ECMO devices is used if the patient is recovering from a cardiac arrest or a lung failure or during a heart surgery. ECMO device is used as a support through the high risk processes in cardiac catheterization labs. It can also be used as a bridge for patients anticipating a lung transplant. The ECMO device helps the tissues to be well oxygenated, this keeps the patient in a better condition for the transplant.
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/14038
The Global market of ECMO devices is driven by the rise in the number of patients going through the respiratory failures and cardiac-pulmonary ailments. Increasing incidences of Chronic obstructive pulmonary disorders (COPD) are also attributing to the increase in the ECMO device market. However, complications associated during the treatment along with the ECMO, comfortable use of the conventional techniques like life support etc. and high costs of ECMO devices are some of the restraints for the ECMO devices market.
ECMO devices are of two types, the VA ECMO device and the VV ECMO device. The VA ECMO is linked to both the vein and an artery. This is used when both the lungs and heart have problem.
The VV ECMO device is connected to one or more veins mostly near the heart. The VV ECMO device is used when the lungs have problem functioning. The third type is artrio venous ECMO device. The portable ECMO device (USCF) is very light weight instrument that can be carried by a person and can even be transported in an ambulance, making it easy to provide ECMO services in emergency cases.
From the global perspective, North America accounts for the largest market share of ECMO devices market owing to the rising demand of ECMO devices because of the increasing incidences of cardiac and pulmonary ailments. Also the patient awareness and safety among the patients and doctors for such type of systems has increased. High adoption rate of ECMO devices in North America probably will help the region to retain the position of the leading region in the forecast years. Europe ECMO devices market will grow because of the technological developments. However, other regions like Asia Pacific, Middle East & Africa are expected to be probable markets in coming years.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/14038
Currently, the global ECMO Devices market is highly competitive due to the participation of many established players. Some of the key players in the global ECMO Devices market are Microport Scientific Corporation, Sorin Group, Terumo Cardiovascular Systems Corporation. Medtronic Plc, Nipro Medical Corporation, Medos Medizintechnik AG and Maquet Holding B. V. & Co.KG.